Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Anthera Pharmaceuticals Inc

+ Add to Watchlist

ANTH:US

5.1100 USD 0.1800 3.65%

As of 17:20:00 ET on 05/27/2015.

Company Profile for Anthera Pharmaceuticals Inc (ANTH)

Anthera Pharmaceuticals Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing anti-inflammatory therapeutics for cardiovascular diseases, lupus and other serious diseases.

Contact Information

Anthera Pharmaceuticals Inc

25801 Industrial Boulevard
Suite B
Hayward, CA 94545
United States
Phone: 1-510-856-5600

Key Executives for Anthera Pharmaceuticals Inc (ANTH)

Paul F TruexPresident/CEO/FounderDebra OdinkSenior VP/CTO
Colin HislopSenior VP/Chief Medical OfcrKlara A Dickinson-EasonSenior VP/Chief Regulatory Ofcr
May LiuSenior VP:Finance & AdministrationPaula AdamsVP:Regulatory Affairs

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisements
Advertisement
sec ||= nil